AI-enabled drug discovery company Xaira launches with $1B
Xaira Therapeutics, an AI-enabled drug discovery and development company, announced its launch with more than $1 billion in capital. The biotechnology company is a joint incubation by ARCH Venture Partners and Foresite Labs, the lead…
Continue Reading